FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15082011000001100: Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53317801000001114 Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53317901000001115 Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Is a Dihydrocodeine 30mg tablets false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Is a Dihydrocodeine 30mg tablets true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Is a Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Dihydrocodeine false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Dihydrocodeine tartrate true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Has AMP True Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) 100 tablet Has AMP True Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) 500 tablet Has AMP True Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start